Molecular Partners Ag (MOLN) Free Cash Flow (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Free Cash Flow of -$18188.4 for Q1 2026, up 1.68% year-on-year from -$17888.1 in Q1 2025, and up 99.97% on a QoQ basis from -$65.0 million in Q4 2025.

Molecular Partners Ag (MOLN) Free Cash Flow (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Free Cash Flow for 7 consecutive years, with -$18188.4 the latest figure, recorded in Q1 2026.

  • Quarterly Free Cash Flow rose 1.68% year-over-year to -$18188.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$63.8 million (up 4.63% YoY) and the FY2025 annual result came in at -$65.0 million, up 4.99% from the prior year.
  • Free Cash Flow advanced to -$18188.4 in Q1 2026 per MOLN's latest filing, from -$65.0 million in the prior quarter.
  • Over the last five years, Free Cash Flow for MOLN reached as high as $157.0 million in Q2 2022 and fell as low as -$156.6 million in Q3 2022.
  • A 5-year average of -$4.4 million and a median of -$18499.0 in 2025 frame the typical range for Free Cash Flow.
  • The largest YoY upside for Free Cash Flow was 633.09% in 2022 against a maximum downside of 375.79% in 2022.
  • Year by year, Free Cash Flow stood at $121.7 million in 2022, then plunged by 155.15% to -$67.1 million in 2023, then fell by 1.89% to -$68.4 million in 2024, then rose by 4.99% to -$65.0 million in 2025, then soared by 99.97% to -$18188.4 in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$18188.4, -$65.0 million, and $37.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - -18,188.38

Historic Data

Download Data
DateValue
Mar 31, 2026 -18,188.38
Mar 31, 2026 -18,188.38
Dec 31, 2025 -64.98 Mn
Dec 31, 2025 -64.98 Mn
Sep 30, 2025 37.00 Mn
Sep 30, 2025 37.00 Mn
Jun 30, 2025 -35.78 Mn
Jun 30, 2025 -35.78 Mn
Mar 31, 2025 -18,498.95
Mar 31, 2025 -18,498.95
Dec 31, 2024 -68.39 Mn
Dec 31, 2024 -68.39 Mn
Sep 30, 2024 37.41 Mn
Sep 30, 2024 37.41 Mn
Jun 30, 2024 -35.87 Mn
Jun 30, 2024 -35.87 Mn
Mar 31, 2024 -19,392.96
Mar 31, 2024 -19,392.96
Dec 31, 2023 -67.12 Mn
Dec 31, 2023 -67.12 Mn